NCT06490003 2025-07-11
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
City of Hope Medical Center
Recruiting
Clinical Trials
12 trialsNCT02394834 2025-05-09
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Takeda
Active not recruiting
NCT04423731 2024-11-20
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)
Oslo University Hospital
Active not recruiting
NCT05489692 2022-08-10
HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma
Sun Yat-sen University
Completed
NCT03446872 2021-09-28
Post Marketing Surveillance Study for ONIVYDE® in South Korea
Servier
Completed
NCT02135887 2020-12-22
MB-6
Microbio Co Ltd
Unknown
NCT03923036 2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT03532711 2018-05-22
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
Fudan University
Completed
NCT01506167 2018-05-14
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
Hoffmann-La Roche
Completed
NCT01533740 2014-02-04
Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients
University of Rome Tor Vergata
Completed
NCT00644020 2008-03-26
Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Unknown